Schedule 13G ownership disclosure

Day One Biopharmaceuticals Inc

Security class unavailable · CUSIP: 23954D109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.3100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-22-001748
Form type
SC 13G
Filer
Day One Biopharmaceuticals, Inc.
CIK
CIK 1845337
Filed
Sep 12, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub